Mycoplasmosis (upper respiratory)

Mycoplasmosis represents one of the most significant infectious diseases affecting tortoises worldwide, causing chronic upper respiratory tract disease (URTD) that has devastated both wild and captive populations. This bacterial infection, primarily caused by Mycoplasma agassizii and related Mycoplasma species, produces progressive damage to the respiratory epithelium resulting in characteristic clinical signs of nasal discharge, ocular problems, and systemic illness. The disease poses particular concern due to its highly contagious nature, chronic carrier state in recovered individuals, and the difficulty of achieving complete cure in affected animals.

Tortoises of virtually all species can be affected by mycoplasmosis, though the disease has caused particularly severe impacts in North American desert tortoise and gopher tortoise populations where it has contributed to significant population declines. In captive collections, Mediterranean species including Hermann's tortoises, Greek tortoises, and Russian tortoises commonly suffer from URTD, as do Sulcata tortoises, red-footed tortoises, and other popular pet species. The disease spreads readily through direct contact, shared food and water sources, and even through contaminated environments, making it a serious threat to multi-tortoise collections and breeding programs.

The impact of mycoplasmosis on tortoise health extends beyond the obvious respiratory symptoms to affect overall vitality, immune function, and long-term survival. Chronically infected tortoises may appear relatively normal between disease flares but remain carriers capable of infecting other tortoises indefinitely. Stress from any cause, including environmental changes, breeding activity, or concurrent illness, can trigger recurrence of active disease. In severe cases, mycoplasmosis can progress to pneumonia, cause permanent damage to respiratory structures, and significantly shorten lifespan. The welfare implications of this chronic, incurable condition are substantial for affected individuals.

Early detection and appropriate management of mycoplasmosis requires veterinary expertise in reptile medicine and understanding of the disease's complex nature. While treatment can control symptoms and reduce pathogen load, complete elimination of Mycoplasma organisms from infected tortoises is rarely achieved. This reality necessitates lifelong management strategies, strict biosecurity protocols to prevent spread, and difficult decisions regarding housing infected individuals separately from uninfected tortoises. Prevention through quarantine, testing, and biosecurity remains far more effective than treatment in managing this challenging disease.

The primary causative agents of mycoplasmosis in tortoises are Mycoplasma agassizii and Mycoplasma testudineum, small bacteria that lack cell walls and belong to a unique class of organisms intermediate between typical bacteria and viruses in size and complexity. These organisms have evolved specialized mechanisms for attaching to and damaging respiratory epithelium, the delicate tissue lining the airways. Once established, Mycoplasma organisms can persist within host tissues for years or even the lifetime of the tortoise, evading immune responses and remaining capable of causing recurrent disease episodes. The lack of a cell wall makes these organisms naturally resistant to many common antibiotics that target cell wall synthesis.

Transmission of mycoplasmosis occurs primarily through direct contact between infected and susceptible tortoises. Nasal discharge from symptomatic animals contains high concentrations of organisms, and nose-to-nose contact during normal social interactions readily spreads infection. The disease can also spread through shared food and water dishes contaminated with nasal discharge, through contaminated substrate, and potentially through aerosol transmission over short distances. Even apparently healthy carrier tortoises can shed organisms and transmit disease, making identification and isolation of infected individuals challenging. The organism can survive in the environment for variable periods depending on temperature and humidity conditions.

Husbandry factors significantly influence both susceptibility to infection and severity of disease following exposure. Tortoises maintained at suboptimal temperatures have compromised immune function and are more susceptible to developing active disease after exposure. Overcrowding increases stress and facilitates transmission between individuals. Poor ventilation allows accumulation of respiratory irritants and pathogens in the environment. Dehydration, common in improperly maintained captive tortoises, reduces the effectiveness of respiratory defenses. Concurrent illness, parasitism, or nutritional deficiencies further compromise immune responses. These husbandry factors explain why identical exposures can produce vastly different outcomes in different tortoises.

Stress acts as a critical trigger for both initial disease development and recurrence in chronically infected individuals. Transport stress, introduction to new environments, breeding activity, hibernation/brumation periods, temperature extremes, and the presence of predators or aggressive cage mates can all trigger disease flares. The stress response suppresses immune function through cortisol release, allowing Mycoplasma organisms that have been held in check by the immune system to replicate and cause active disease. Understanding stress triggers helps explain the episodic nature of clinical signs in chronically infected tortoises and guides management strategies.

The pathophysiology of mycoplasmosis involves progressive destruction of respiratory epithelium with resulting dysfunction of normal respiratory defenses. Mycoplasma organisms attach to epithelial cells and produce toxins and enzymes that damage cell membranes and cilia, the tiny hair-like structures that normally sweep debris and pathogens out of the respiratory tract. This damage leads to accumulation of mucus and inflammatory debris in the nasal passages and sinuses, producing the characteristic discharge. Chronic inflammation can cause permanent structural changes including thickening and scarring of respiratory tissues, loss of turbinate bones in the nasal passages, and increased susceptibility to secondary bacterial infections.

Early symptoms of mycoplasmosis in tortoises can be subtle and easily overlooked, particularly in the initial stages of infection or in chronically infected individuals during quiescent periods. Occasional clear nasal discharge, sometimes visible only as slightly wet nares, may be the only early indication of infection. Mild lethargy and slightly decreased appetite might be noticed by observant keepers but are often attributed to other causes. Some tortoises may show increased basking behavior as they attempt to raise body temperature in response to early infection. These early signs warrant veterinary investigation, as intervention at this stage offers the best opportunity for effective management.

The hallmark symptom of established mycoplasmosis is nasal discharge, which progresses characteristically as disease advances. Initial discharge is typically clear and watery but becomes increasingly thick, mucoid, and eventually purulent (containing pus) as secondary bacterial infections develop. Discharge may be unilateral (affecting one nostril) or bilateral, and affected tortoises often exhibit bubbling or frothing at the nares during breathing. The discharge may dry around the nares, creating crusty accumulations that further obstruct breathing. In severe cases, thick discharge can completely occlude the nasal passages, forcing mouth breathing and significantly compromising respiratory function.

Behavioral changes accompany the physical symptoms of mycoplasmosis and provide important diagnostic clues. Affected tortoises commonly demonstrate open-mouth breathing or gaping, particularly after exertion or during warm periods when respiratory demands increase. Audible respiratory sounds including wheezing, clicking, or whistling may be heard, indicating airway obstruction. Affected individuals often show reduced activity, spending more time resting and less time engaged in normal exploratory and feeding behaviors. Appetite typically decreases progressively, and weight loss develops in chronically affected tortoises. Social withdrawal becomes apparent in group-housed animals, with sick individuals isolating themselves from companions.

Ocular symptoms frequently accompany respiratory signs in mycoplasmosis cases. Eye discharge, conjunctivitis (inflammation of the membranes around the eye), and swollen eyelids are common manifestations. The eyes may appear sunken in dehydrated individuals, or periocular tissues may appear puffy and swollen with inflammation. Some tortoises develop difficulty opening their eyes due to accumulated discharge and inflammation. Corneal damage can occur in severe or chronic cases, potentially affecting vision. The combination of nasal and ocular discharge is highly suggestive of mycoplasmosis, though similar presentations can result from other infections.

Symptom progression in untreated or inadequately managed mycoplasmosis follows a pattern of gradual worsening interspersed with periods of relative stability or apparent improvement. Clinical signs typically worsen during stress, suboptimal temperatures, or concurrent illness, then may partially improve as the immune system partially controls the infection. However, each episode tends to cause incremental permanent damage to respiratory structures. Over months to years, affected tortoises develop increasingly severe baseline symptoms as accumulated damage compromises respiratory function. Some individuals progress to chronic weight loss, severe debilitation, and secondary pneumonia.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with pronounced open-mouth breathing, cyanosis (bluish discoloration) of mucous membranes indicating oxygen deprivation, complete anorexia for more than one week, severe dehydration, collapse or extreme weakness, and any signs of pneumonia including altered breathing sounds heard throughout the body cavity. These symptoms indicate life-threatening disease progression requiring aggressive intervention including possible hospitalization, injectable antibiotics, fluid therapy, and intensive supportive care. Delay at this stage significantly worsens prognosis.

Diagnosis of mycoplasmosis in tortoises requires a combination of clinical evaluation, specific laboratory testing, and exclusion of other causes of upper respiratory disease. Physical examination by a reptile-experienced veterinarian assesses the character and extent of nasal discharge, respiratory sounds, hydration status, body condition, and overall health. The examination includes careful inspection of the nares for discharge accumulation and tissue changes, auscultation of the respiratory system to detect abnormal sounds, and assessment of the eyes for concurrent involvement. Clinical signs alone cannot definitively diagnose mycoplasmosis, as similar presentations occur with other respiratory pathogens, but they guide appropriate testing strategies.

Specific laboratory testing for Mycoplasma organisms provides definitive diagnosis. Polymerase chain reaction (PCR) testing detects genetic material from Mycoplasma organisms in nasal swab or wash samples, offering high sensitivity and specificity for identifying active infections. Enzyme-linked immunosorbent assay (ELISA) testing detects antibodies against Mycoplasma in blood samples, indicating current or past exposure. Both tests have limitations: PCR may miss organisms present in low numbers or in tissue reservoirs not reached by sampling, while antibody tests cannot distinguish between active infection and previous exposure with resolution. Some veterinarians recommend testing with both methods for comprehensive evaluation.

Additional diagnostic testing helps assess disease severity and identify concurrent problems. Radiographs (X-rays) of the skull and body cavity can reveal thickening of nasal passages, bone destruction from chronic infection, and any involvement of the lower respiratory tract including pneumonia. Blood work evaluates overall health status, identifies secondary complications, and provides baseline values for monitoring treatment response. Bacterial culture and sensitivity testing from nasal discharge identifies secondary bacterial infections and guides antibiotic selection. Nasal endoscopy, where available, allows direct visualization of nasal structures and assessment of damage extent.

Differential diagnosis must consider other causes of upper respiratory symptoms in tortoises. Herpesvirus infections cause similar clinical signs and may co-occur with mycoplasmosis. Bacterial infections from other organisms, including Pasteurella and other opportunistic pathogens, produce respiratory disease. Vitamin A deficiency causes squamous metaplasia of respiratory epithelium with resulting increased susceptibility to infection. Foreign bodies, tumors, and traumatic injuries can cause unilateral discharge. Environmental irritants including dusty substrates, poor ventilation, and chemical exposure may produce respiratory symptoms. Thorough evaluation including specific testing differentiates mycoplasmosis from these alternatives and identifies any concurrent conditions requiring treatment.

Treatment of mycoplasmosis in tortoises focuses on controlling clinical signs, reducing pathogen load, and supporting the immune system, with the understanding that complete cure is rarely achieved. Antibiotic therapy forms the cornerstone of medical management, though antibiotic selection must account for the unique biology of Mycoplasma organisms. Because these bacteria lack cell walls, antibiotics targeting cell wall synthesis (including penicillins and cephalosporins) are ineffective. Effective antibiotics include fluoroquinolones such as enrofloxacin, macrolides such as clarithromycin or azithromycin, and tetracyclines. Treatment duration typically extends four to six weeks or longer, as shorter courses fail to adequately suppress organisms in tissue reservoirs.

Supportive care significantly impacts treatment outcomes and should be implemented alongside antibiotic therapy. Hydration support through regular soaking in shallow warm water and, in hospitalized patients, subcutaneous or intracoelonic fluid administration maintains kidney function and helps thin respiratory secretions. Nutritional support ensures adequate caloric intake during recovery, with assist feeding of herbivore formulas necessary for tortoises that have stopped eating independently. Nasal flushing with sterile saline, performed by veterinary staff, helps clear accumulated discharge and may improve antibiotic penetration to affected tissues. Nebulization therapy delivering aerosolized medications directly to respiratory tissues may be recommended for severe cases.

Husbandry optimization is essential for successful treatment and must address all factors that compromise immune function. Temperature should be maintained at the upper end of the species-specific preferred range to support immune function and drug metabolism. Humidity optimization helps maintain respiratory mucous membrane health and facilitates clearance of respiratory secretions. Clean, well-ventilated housing reduces pathogen load in the environment and prevents reinfection. Stress reduction through stable environmental conditions, appropriate hiding areas, and separation from aggressive cage mates supports recovery. These husbandry improvements are therapeutic in themselves and dramatically improve response to medical treatment.

Treatment of secondary complications often accompanies primary mycoplasmosis management. Secondary bacterial infections, common in chronic cases, may require additional antibiotics based on culture and sensitivity results. Eye involvement may necessitate topical ophthalmic treatments. Severe dehydration requires aggressive fluid therapy. Nutritional deficiencies identified during evaluation should be corrected through dietary modification and supplementation. Concurrent parasitism should be addressed with appropriate antiparasitic treatments. Managing these secondary issues improves overall response to treatment.

Species-specific considerations influence treatment approaches and prognosis. Desert tortoises and gopher tortoises face particular challenges due to the severity of disease in these populations and regulatory considerations affecting treatment options for protected species. Small tortoise species may be more difficult to treat due to challenges with drug dosing and supportive care. Species with high metabolic rates may metabolize medications differently than slower-metabolism species. Individual variation in immune competence affects treatment response regardless of species. Close veterinary monitoring with treatment adjustments based on response is essential.

Treatment timeline extends over weeks to months for initial disease control, with the understanding that ongoing management is typically required. Clinical improvement may be visible within one to two weeks of starting treatment, but premature discontinuation leads to rapid relapse. Complete resolution of clinical signs may take six to eight weeks or longer. Following initial treatment, many tortoises require ongoing monitoring and intermittent treatment during stress periods or disease flares. Some chronically infected individuals benefit from periodic pulse antibiotic therapy to maintain disease control. Owner education regarding the chronic nature of this disease and realistic expectations is an essential component of treatment planning.

Recovery from active mycoplasmosis episodes involves gradual resolution of clinical signs over weeks to months with appropriate treatment and husbandry optimization. Nasal discharge typically begins to decrease within the first two weeks of treatment, progressing from purulent to mucoid to clear as infection comes under control and secondary bacterial involvement resolves. Appetite and activity levels improve as the tortoise feels better, though full return to normal behavior may take longer than resolution of obvious respiratory symptoms. Weight stabilization and then gradual regain indicates successful management, while continued weight loss despite treatment suggests inadequate response requiring strategy modification.

Post-treatment management recognizes that most tortoises remain chronic carriers following apparent recovery from mycoplasmosis. These animals appear healthy and may show no clinical signs for extended periods but continue to harbor Mycoplasma organisms capable of causing recurrent disease under stress. Post-treatment testing with PCR may show persistent infection even in clinically recovered animals. Understanding this carrier state is essential for making appropriate housing decisions and preventing transmission to uninfected tortoises. Recovered carriers should be considered permanently potentially infectious and managed accordingly.

Prognosis for tortoises with mycoplasmosis varies considerably based on disease severity at diagnosis, extent of permanent respiratory damage, species, and individual immune competence. Tortoises diagnosed early with mild disease and minimal structural damage can often achieve long-term clinical remission with appropriate management. Those with chronic disease and significant permanent damage may experience recurrent episodes despite treatment and face shortened lifespans. Species susceptibility varies, with some individuals apparently able to mount more effective immune responses than others. Overall, mycoplasmosis should be considered a chronic manageable condition rather than a curable disease, with quality of life maintained through ongoing appropriate care.

Long-term monitoring of recovered or stabilized mycoplasmosis cases includes regular veterinary examinations to assess respiratory status, prompt attention to any recurrence of symptoms, and careful observation for disease flares during stress periods. Owners should maintain logs of any symptoms observed, stressors encountered, and environmental conditions. Periodic PCR testing may help assess infection status. Weight monitoring provides objective evidence of overall health status. This ongoing vigilance allows early intervention during relapses, which typically respond better to treatment than the initial disease episode due to established management protocols and owner experience.

Prevention of mycoplasmosis begins with rigorous quarantine protocols for any new tortoises entering a collection or home. New acquisitions should be housed in completely separate facilities, ideally in a different building or at minimum in a separate room with no shared air handling, for a minimum of ninety days. During quarantine, tortoises should be observed daily for any respiratory symptoms and ideally tested for Mycoplasma through PCR and/or antibody testing. Quarantine housing should be easy to disinfect and should not share any equipment with established collections. Only after completing quarantine with no symptoms and negative testing should new tortoises be considered for introduction to other animals.

Biosecurity practices prevent transmission within collections and from outside sources. Dedicated equipment for each enclosure or group of tortoises prevents mechanical transmission between animals. Handwashing between handling different tortoises is essential. New tortoises should never be introduced directly into established groups. Outdoor enclosures should prevent contact with wild tortoises or other reptiles that could carry infection. Visitors should not be permitted to handle tortoises without handwashing, and contact with tortoises from other collections should be avoided. These practices may seem excessive but are essential for preventing introduction of this devastating disease.

Husbandry optimization maintains immune competence and reduces susceptibility to infection. Proper temperature gradients with appropriate basking spots and cool retreat areas support normal immune function. Adequate humidity prevents respiratory epithelium drying and maintains normal defensive functions. Clean, well-ventilated enclosures reduce pathogen exposure. Appropriate diet with proper supplementation supports overall health. Stress reduction through stable environments, appropriate social groupings, and avoidance of unnecessary handling maintains immune vigilance. Tortoises maintained under optimal conditions can better resist infection if exposed and experience less severe disease if infected.

Testing programs identify infected individuals before they can transmit disease to collections or breeding groups. All tortoises in breeding programs should be tested and only confirmed negative animals bred. Purchased tortoises should come with recent negative test results from reputable laboratories, though quarantine and retesting remain essential regardless. Annual testing of collection animals provides ongoing surveillance for disease introduction. Group testing strategies can identify infected populations efficiently. Working with a veterinarian experienced in reptile medicine ensures appropriate test selection and interpretation.

Education regarding mycoplasmosis transmission and prevention empowers tortoise keepers to protect their animals. Understanding that healthy-appearing tortoises can be infectious emphasizes the importance of quarantine and testing. Recognizing early symptoms enables prompt veterinary consultation before advanced disease develops. Awareness of stress triggers for disease recurrence guides management of recovered carriers. Knowledge of the chronic, incurable nature of this disease motivates prevention efforts. Participation in tortoise keeping communities facilitates information sharing about disease outbreaks and prevention strategies.

Living with a mycoplasmosis-positive tortoise requires adaptation of husbandry practices and acceptance of the chronic nature of this condition. Housing decisions must account for the contagious nature of the disease, typically meaning permanent separation from uninfected tortoises. Single-animal housing or grouping only with other confirmed-positive individuals prevents transmission to healthy animals. Equipment must remain dedicated to the infected animal or group. Caregiving order should place uninfected animals first, followed by thorough handwashing and clothing change before caring for positive animals. These biosecurity measures become permanent features of daily husbandry routines.

Environmental management for mycoplasmosis-positive tortoises emphasizes support of immune function and respiratory health. Temperature maintenance at optimal levels, including ensuring functional heating equipment with backup systems, prevents the immune suppression associated with suboptimal temperatures. Humidity appropriate for the species helps maintain respiratory epithelium health. Excellent ventilation reduces airborne pathogen load while avoiding drafts that could cause chilling. Dust-free substrates prevent respiratory irritation. Clean water provided daily ensures hydration supporting respiratory defenses. Regular enclosure cleaning reduces environmental pathogen accumulation. This enhanced environmental management becomes the new standard of care.

Health monitoring takes on increased importance for tortoises with mycoplasmosis. Daily observation notes any respiratory symptoms, changes in behavior, or alterations in appetite. Weekly weigh-ins track body condition and provide early warning of relapses. Seasonal monitoring intensifies during stress periods including spring emergence, breeding season, and fall pre-brumation period when disease flares commonly occur. Maintaining detailed health logs provides valuable information for recognizing patterns and optimizing management. Any worsening of symptoms warrants prompt veterinary consultation rather than waiting to see if improvement occurs spontaneously.

Quality of life assessment guides decisions about ongoing care intensity and prognosis. Tortoises maintaining good appetite, normal activity, and stable weight despite chronic infection can enjoy good quality of life with appropriate management. Those experiencing frequent severe relapses, progressive weight loss despite treatment, or significant permanent respiratory compromise require honest assessment of welfare. Palliative care focused on comfort may become appropriate for severely affected individuals. Euthanasia should be considered when suffering cannot be adequately managed and quality of life is consistently poor. These difficult decisions benefit from guidance from a veterinarian experienced with tortoise care.

Long-term planning for chronically infected tortoises addresses the extended timeframe of this condition. Budgeting for ongoing veterinary care, periodic testing, and possible emergency treatment ensures resources are available when needed. Identifying veterinarians with tortoise expertise in your area and establishing relationships before emergencies occur facilitates prompt care access. Planning for owner absence or inability to provide care ensures continuity of appropriate management. Documentation of the tortoise's medical history, current protocols, and specific care requirements enables other caregivers to maintain proper management. Given the potential for tortoises to live decades, this planning must account for circumstances that may change over extended periods.

Desert tortoises (Gopherus agassizii and Gopherus morafkai) face particularly severe impacts from mycoplasmosis, with the disease contributing to significant population declines in wild populations across the American Southwest. These federally protected species experience high mortality rates from URTD, and the disease has complicated conservation efforts. Captive desert tortoises remain highly susceptible, and strict regulations govern keeping and movement of these animals in part to prevent disease spread. The severity of disease in desert tortoises relates to both pathogen virulence and species-specific immune characteristics that may limit ability to control infection.

Gopher tortoises (Gopherus polyphemus) of the southeastern United States similarly experience significant mycoplasmosis impacts. Wild populations have suffered substantial declines attributed partially to URTD, leading to protected status in many states. The disease spreads readily within gopher tortoise populations due to their colonial habits and burrow sharing. Captive gopher tortoises require the same careful biosecurity as desert tortoises, and regulations restrict their keeping and movement. Recovery efforts for wild populations must account for disease management as well as habitat protection.

Mediterranean tortoise species commonly kept as pets, including Hermann's tortoises, Greek tortoises, Marginated tortoises, and Russian tortoises, experience high rates of mycoplasmosis in captive populations. The pet trade has facilitated disease spread as infected animals move between collections, and many tortoises entering the market carry infection asymptomatically. Russian tortoises, often wild-caught and imported under stressful conditions, frequently arrive already infected or particularly susceptible due to stress-induced immune suppression. The small size and perceived hardiness of these species can lead to underestimation of their veterinary needs, delaying diagnosis and treatment. All tortoises from unknown health status sources should be considered potential mycoplasmosis carriers and managed accordingly.

Herpesvirus infection represents the most significant condition commonly co-occurring with mycoplasmosis in tortoises. Tortoise herpesvirus causes similar upper respiratory symptoms and can be difficult to distinguish clinically from mycoplasmosis. Many tortoises carry both infections simultaneously, with each potentially exacerbating the other. Testing for both pathogens is recommended when respiratory disease is present, as management strategies differ and concurrent treatment may be necessary. Like mycoplasmosis, herpesvirus establishes persistent latent infections that can reactivate under stress.

Conditions presenting with similar symptoms to mycoplasmosis require differentiation for appropriate treatment. Vitamin A deficiency causes changes to respiratory epithelium that increase susceptibility to infection and can produce discharge even without specific pathogens. Bacterial infections with organisms other than Mycoplasma, including Pasteurella and other opportunists, cause respiratory disease with similar presentation. Environmental irritants produce rhinitis and discharge without infectious cause. Nasal foreign bodies cause unilateral discharge. Appropriate diagnostic testing differentiates these conditions, though multiple concurrent problems are common.

Secondary complications of mycoplasmosis significantly impact affected tortoises. Secondary bacterial infections of damaged respiratory tissue are extremely common and contribute substantially to clinical disease. Pneumonia develops when infection extends to lower airways, dramatically worsening prognosis. Dehydration results from decreased water intake and increased respiratory losses. Malnutrition follows appetite depression in chronic cases. Immune exhaustion from chronic infection can increase susceptibility to other diseases. Effective mycoplasmosis management must address these secondary issues alongside the primary infection to achieve optimal outcomes.